drugset / Trial / NCT00571727

Long-Term Treatment With rhIGF-1 in GHIS

NCT00571727

Phase 2/3 Completed 92 enrolled Ipsen University of Oklahoma · collab
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study was to evaluate the long-term safety and effectiveness of mecasermin (the study drug) in children with growth failure due to severe Primary insulin-like growth factor-1 deficiency (Primary IGFD).

Timeline

Start
1991-05-20
Primary completion
2011-12-15
Completion
2011-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject mecasermin Protein / enzyme biologic 60 ug/kg Subcutaneous
Subject mecasermin Protein / enzyme biologic 120 ug/kg Subcutaneous